Awesome article! It concisely describes our experience moving from pure AI expertise to applied drug discovery. And I like viewing drug discovery as a data gap-filling process.
How do these frameworks apply or miss when it comes to tools for operations like clinical trial recruitment, site selection, etc.? How should startups building these tools be thinking about selling to pharma directly, vs. vendors like CROs?
Purely outstanding article!
A lot of insights and clearly defined hard problems with no simple solutions.
Thank you so much, Brandon, for writing and sharing this!
Awesome article! It concisely describes our experience moving from pure AI expertise to applied drug discovery. And I like viewing drug discovery as a data gap-filling process.
Now I know how to sell AI to big pharma!
How do these frameworks apply or miss when it comes to tools for operations like clinical trial recruitment, site selection, etc.? How should startups building these tools be thinking about selling to pharma directly, vs. vendors like CROs?